Biological micro-pancreas for insulin-dependent diabetics company
January 11, 2017
On January 11, 2017 Betalin Therapeutics completed their seed funding round with €50,000 in funding from the European Union executive agency for SMEs.
On January 11, 2017 Betalin Therapeutics completed their seed funding round with €50,000 in funding from the European Union executive agency for SMEs.